
Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

